Prevention of Maternal Hypotension During Cesarean Section With Norepinephrine Infusion.

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 26, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
HypotensionObstetric Anesthesia ProblemsCesarean Section ComplicationsHypotensiveVasoconstriction
Interventions
PROCEDURE

norepinephrine infusion and colloid preloading (NOR-COL)

in parturients allocated to the NOR-COL group, a norepinephrine infusion will be started as soon as spinal anesthesia is initiated. This group will also receive 5 mL/kg of colloid infusion prior to the initiation of spinal anesthesia

PROCEDURE

norepinephrine infusion and crystalloid co-loading (NOR-CRYST)

in parturients allocated to the NOR-CRYST group, a norepinephrine infusion will be started as soon as spinal anesthesia is initiated. This group will also receive 10 mL/kg of crystalloid infusion simultaneously with the initiation of spinal anesthesia

Trial Locations (2)

11528

Alexandra General Hospital of Athens, Athens

115 28

Aretaieion University Hospital, Athens

All Listed Sponsors
collaborator

Alexandra Hospital, Athens, Greece

OTHER

lead

Aretaieion University Hospital

OTHER

NCT04406051 - Prevention of Maternal Hypotension During Cesarean Section With Norepinephrine Infusion. | Biotech Hunter | Biotech Hunter